Impella 5.5 as a bridge to heart transplantation: Waitlist outcomes in the United States.

Marisa CevascoMax ShinWilliam CohenMark R HelmersNoah WeingartenDavid RekhtmanJoyce W WaldAmit Iyengar

Published in: Clinical transplantation (2023)

Since its approval, the Impella 5.5 has been increasingly used as a bridge to transplant. This analysis demonstrates robust waitlist and post-transplant outcomes with minimal device-related and postoperative complications.

Keyphrases

extracorporeal membrane oxygenation
left ventricular assist device
metabolic syndrome
skeletal muscle
drug administration